These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12507777)

  • 1. Suppressed clinical experimental autoimmune myasthenia gravis in bm12 mice is linked to reduced intracellular calcium mobilization and IL-10 and IFN-gamma release by acetylcholine receptor-specific T cells.
    Poussin MA; Fuller CL; Goluszko E; Reyes VE; Braciale VL; Christadoss P
    J Neuroimmunol; 2003 Jan; 134(1-2):104-10. PubMed ID: 12507777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR.
    Poussin MA; Goluszko E; Hughes TK; Duchicella SI; Christadoss P
    J Neuroimmunol; 2000 Nov; 111(1-2):152-60. PubMed ID: 11063833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M; Oshima M; Atassi MZ; Christadoss P
    Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production.
    Poussin MA; Goluszko E; David CS; Franco JU; Christadoss P
    J Autoimmun; 2001 Nov; 17(3):175-80. PubMed ID: 11712854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis.
    Yang H; Kala M; Scott BG; Goluszko E; Chapman HA; Christadoss P
    J Immunol; 2005 Feb; 174(3):1729-37. PubMed ID: 15661938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis.
    Dedhia V; Goluszko E; Wu B; Deng C; Christadoss P
    Clin Immunol Immunopathol; 1998 Jun; 87(3):266-75. PubMed ID: 9646836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.
    Wang W; Milani M; Ostlie N; Okita D; Agarwal RK; Caspi RR; Conti-Fine BM
    J Immunol; 2007 Jun; 178(11):7072-80. PubMed ID: 17513756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II:acetylcholine receptor peptide complexes.
    Spack EG; McCutcheon M; Corbelletta N; Nag B; Passmore D; Sharma SD
    J Autoimmun; 1995 Dec; 8(6):787-807. PubMed ID: 8824707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C; Goluszko E; Christadoss P
    J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.
    Ostlie N; Milani M; Wang W; Okita D; Conti-Fine BM
    J Immunol; 2003 Jan; 170(1):604-12. PubMed ID: 12496449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162.
    Oshima M; Atassi MZ
    J Immunol; 1995 May; 154(10):5245-54. PubMed ID: 7537303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Huang WX
    Scand J Immunol; 1993 May; 37(5):615-22. PubMed ID: 7683442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice.
    Karachunski PI; Ostlie N; Bellone M; Infante AJ; Conti-Fine BM
    Scand J Immunol; 1995 Aug; 42(2):215-25. PubMed ID: 7631155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis.
    Feferman T; Im SH; Fuchs S; Souroujon MC
    J Neuroimmunol; 2003 Jul; 140(1-2):153-8. PubMed ID: 12864983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis.
    Yang B; McIntosh KR; Drachman DB
    Clin Immunol Immunopathol; 1998 Jan; 86(1):45-58. PubMed ID: 9434796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis.
    Wu B; Deng C; Goluszko E; Christadoss P
    J Immunol; 1997 Sep; 159(6):3016-23. PubMed ID: 9300727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.